You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Funding from RADx and NIAID will enable the scale-up of multiplexed viral detection microarrays to 4 million tests per month.
The firm's new Oracle 3D glass nanowell microarray substrates are targeted towards customers that use protein arrays for research, in drug discovery, and, potentially, in the clinic.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.